A new study has found that naturalistic psilocybin use is associated with improvements in mental health, but the extent and duration of these benefits differ between racial groups. The research, which analysed data from over 2,800 participants, examined how the effects of psilocybin use varied between White individuals and non-white groups over a period of months. The findings were published in the Journal of Affective Disorders.
The study focused on a range of psychological measures, including depression, anxiety, spiritual well-being, cognitive flexibility, and emotion regulation. Results showed that both White participants and non-White groups experienced reductions in depression and anxiety following psilocybin use. But the study found that spiritual well-being and cognitive flexibility improvements were more pronounced and longer-lasting in White participants. In contrast, for non-white groups, these benefits diminished over time.
Another key finding was that White participants exhibited a reduction in expressive suppression, a form of emotion regulation where individuals conceal their emotions. This change was not observed in non-white groups. Researchers suggest that expressive suppression may serve a different function for racial minorities, potentially as a protective mechanism in social contexts. The study highlights the need for further research into how sociocultural factors influence the psychological effects of psychedelics.
While the study confirmed positive effects of psilocybin use in naturalistic settings, it also revealed disparities in how these benefits manifest across different racial groups. Non-white groups were more likely to set an intention before using psilocybin, a practice associated with better psychological outcomes, yet they still showed less improvement in certain measures compared to their White counterparts.
The findings raise important questions about how race and social environment shape responses to psychedelics. The study suggests that factors such as cultural attitudes towards drug use, access to supportive settings, and broader systemic issues could all play a role in these differences. These insights could inform future research and clinical applications of psychedelic-assisted therapy to ensure equitable mental health benefits for all populations.
Despite the study’s contributions, researchers acknowledge its limitations. The data was collected online, making it reliant on self-reporting, and the sample was not fully representative of the wider population. Additionally, non-white groups were grouped together, which may overlook differences between specific racial and ethnic groups.






